相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Investigation of In-vitro Efficacy of Intravenous Fosfomycin in Extensively Drug-Resistant Klebsiella pneumoniae Isolates and Effect of Glucose 6-Phosphate on Sensitivity Results
Ozlem Aydemir et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment
Yu-Lin Lee et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group
Truls E. Bjerklund Johansen et al.
European Urology Focus (2021)
Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection A Randomized Clinical Trial
Dimitri M. Drekonja et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies
Roberta Maria Antonello et al.
ANTIBIOTICS-BASEL (2020)
Oral fosfomycin for the treatment of chronic bacterial prostatitis
Ilias Karaiskos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli
George G. Zhanel et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2018)
Which non-carbapenem antibiotics are active against extended-spectrum β-lactamase-producing Enterobacteriaceae?
Helene Bouxom et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Practice guidelines for the management of adult community-acquired urinary tract infections
F. Caron et al.
MEDECINE ET MALADIES INFECTIEUSES (2018)
Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study
Louise Rossignol et al.
INFECTION (2017)
Comprehensive overview of prostatitis
Farhan Ullah Khan et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States
S. M. Bartsch et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis
Ibai Los-Arcos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study
Philippa C. Matthews et al.
BMC INFECTIOUS DISEASES (2016)
Bacterial prostatitis
Bradley C. Gill et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2016)
Raoultella planticola chronic bacterial prostatitis with prostatic calcifications: successful treatment with prolonged fosfomycin therapy
John Gian et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections
Michael P. Veve et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in community-onset urinary tract infections in France in 2013
D. Martin et al.
JOURNAL OF INFECTION (2016)
Fosfomycine, place et intérêt dans un contexte de multirésistance
A. Pourbaix et al.
Journal des Anti-infectieux (2016)
Fosfomycin: The Current Status of the Drug
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2015)
Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs
M. Lindsay Grayson et al.
CLINICAL INFECTIOUS DISEASES (2015)
Persistent extended-spectrum β-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline
Burke A. Cunha et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis
Nathaniel J. Rhodes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Successful treatment of lower urinary tract infections with oral fosfomycin: a report of three cases
Juliana Oliveira da Silva et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2015)
Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis?
B. J. Gardiner et al.
CLINICAL INFECTIOUS DISEASES (2014)
Global antibiotic consumption 2000 to 2010: an analysis of Cross Mark 742 national pharmaceutical sales data
Thomas P. Van Boeckel et al.
LANCET INFECTIOUS DISEASES (2014)
The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: results from a longitudinal cohort study
Riccardo Bartoletti et al.
WORLD JOURNAL OF UROLOGY (2014)
Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey
Tulin Demir et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2013)
Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study
Lu-Dong Qiao et al.
BMJ OPEN (2013)
Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms
Elizabeth A. Neuner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Carbapenem Versus Fosfomycin Tromethanol in the Treatment of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli-Related Complicated Lower Urinary Tract Infection
S. Senol et al.
JOURNAL OF CHEMOTHERAPY (2010)
Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern
Johann D. D. Pitout et al.
LANCET INFECTIOUS DISEASES (2008)
Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections
Husnu Pullukcu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
The CTX-M β-lactamase pandemic
Rafael Canton et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Comparison of susceptibility testing procedures
M de Cueto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis
K Gupta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Penetration of antimicrobial agents into the prostate
K Charalabopoulos et al.
CHEMOTHERAPY (2003)
In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance
A Marchese et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
分享论文
